Brief: Biodexa Announces Enrolment Of First European Patients Into Pivotal Phase 3 Serenta Trial In FAP

Biodexa Pharmaceuticals

01/12/2025 13:33

Dec 1 (Reuters) - Biodexa Pharmaceuticals PLC 5MPy.F:

BIODEXA ANNOUNCES ENROLMENT OF FIRST EUROPEAN PATIENTS  INTO PIVOTAL PHASE 3 SERENTA TRIAL IN FAP

Source text: ID:nGNX1R1m8y

Further company coverage: [5MPy.F]

 ((Reuters.Briefs@thomsonreuters.com;))